Pediatrix Medical Debt to Equity Ratio 2010-2024 | MD
Current and historical debt to equity ratio values for Pediatrix Medical (MD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pediatrix Medical debt/equity for the three months ending March 31, 2024 was 0.81.
| Pediatrix Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $1.31B | $0.86B | 1.53 |
| 2023-12-31 | $1.37B | $0.85B | 1.61 |
| 2023-09-30 | $1.36B | $0.97B | 1.40 |
| 2023-06-30 | $1.36B | $0.94B | 1.45 |
| 2023-03-31 | $1.41B | $0.91B | 1.55 |
| 2022-12-31 | $1.46B | $0.89B | 1.63 |
| 2022-09-30 | $1.47B | $0.86B | 1.72 |
| 2022-06-30 | $1.52B | $0.85B | 1.80 |
| 2022-03-31 | $1.46B | $0.88B | 1.67 |
| 2021-12-31 | $1.83B | $0.90B | 2.04 |
| 2021-09-30 | $1.80B | $0.85B | 2.13 |
| 2021-06-30 | $1.75B | $0.81B | 2.16 |
| 2021-03-31 | $1.72B | $0.77B | 2.24 |
| 2020-12-31 | $2.60B | $0.75B | 3.48 |
| 2020-09-30 | $2.62B | $0.81B | 3.25 |
| 2020-06-30 | $2.56B | $0.83B | 3.10 |
| 2020-03-31 | $2.83B | $1.49B | 1.90 |
| 2019-12-31 | $2.65B | $1.50B | 1.77 |
| 2019-09-30 | $2.81B | $1.48B | 1.90 |
| 2019-06-30 | $2.91B | $2.73B | 1.07 |
| 2019-03-31 | $2.93B | $2.78B | 1.05 |
| 2018-12-31 | $2.85B | $3.09B | 0.92 |
| 2018-09-30 | $2.82B | $3.02B | 0.94 |
| 2018-06-30 | $2.67B | $3.19B | 0.84 |
| 2018-03-31 | $2.74B | $3.14B | 0.87 |
| 2017-12-31 | $2.80B | $3.07B | 0.91 |
| 2017-09-30 | $2.76B | $2.92B | 0.95 |
| 2017-06-30 | $2.57B | $2.84B | 0.91 |
| 2017-03-31 | $2.66B | $2.76B | 0.96 |
| 2016-12-31 | $2.58B | $2.76B | 0.93 |
| 2016-09-30 | $2.68B | $2.67B | 1.00 |
| 2016-06-30 | $2.21B | $2.56B | 0.87 |
| 2016-03-31 | $2.18B | $2.46B | 0.88 |
| 2015-12-31 | $2.11B | $2.44B | 0.87 |
| 2015-09-30 | $2.21B | $2.33B | 0.95 |
| 2015-06-30 | $2.06B | $2.22B | 0.93 |
| 2015-03-31 | $1.53B | $2.11B | 0.73 |
| 2014-12-31 | $1.34B | $2.27B | 0.59 |
| 2014-09-30 | $0.97B | $2.51B | 0.39 |
| 2014-06-30 | $0.77B | $2.41B | 0.32 |
| 2014-03-31 | $0.79B | $2.31B | 0.34 |
| 2013-12-31 | $0.67B | $2.34B | 0.28 |
| 2013-09-30 | $0.75B | $2.23B | 0.33 |
| 2013-06-30 | $0.70B | $2.19B | 0.32 |
| 2013-03-31 | $0.69B | $2.11B | 0.33 |
| 2012-12-31 | $0.72B | $2.04B | 0.35 |
| 2012-09-30 | $0.58B | $1.95B | 0.30 |
| 2012-06-30 | $0.48B | $1.87B | 0.26 |
| 2012-03-31 | $0.53B | $1.80B | 0.29 |
| 2011-12-31 | $0.54B | $1.73B | 0.31 |
| 2011-09-30 | $0.52B | $1.66B | 0.31 |
| 2011-06-30 | $0.48B | $1.59B | 0.30 |
| 2011-03-31 | $0.56B | $1.51B | 0.37 |
| 2010-12-31 | $0.59B | $1.45B | 0.41 |
| 2010-09-30 | $0.43B | $1.37B | 0.31 |
| 2010-06-30 | $0.46B | $1.30B | 0.35 |
| 2010-03-31 | $0.50B | $1.24B | 0.41 |
| 2009-12-31 | $0.50B | $1.19B | 0.42 |
| 2009-09-30 | $0.54B | $1.12B | 0.48 |
| 2009-06-30 | $0.53B | $1.06B | 0.50 |
| 2009-03-31 | $0.52B | $1.01B | 0.51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.673B | $1.995B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.209B | 15.59 |
| Cencora (COR) | United States | $47.206B | 18.40 |
| ICON (ICLR) | Ireland | $26.298B | 24.83 |
| DiDi Global (DIDIY) | China | $21.580B | 0.00 |
| Avantor (AVTR) | United States | $15.025B | 22.12 |
| CochLear (CHEOY) | Australia | $14.104B | 0.00 |
| Revvity (RVTY) | United States | $13.324B | 23.37 |
| Natera (NTRA) | United States | $13.153B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.518B | 41.19 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.906B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.900B | 20.87 |
| Solventum (SOLV) | United States | $9.041B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.666B | 0.00 |
| HealthEquity (HQY) | United States | $7.278B | 46.73 |
| Organon (OGN) | United States | $5.359B | 5.08 |
| Bausch + Lomb (BLCO) | Canada | $5.253B | 21.03 |
| Doximity (DOCS) | United States | $5.103B | 35.74 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.659B | 38.33 |
| Sotera Health (SHC) | United States | $3.400B | 16.68 |
| Surgery Partners (SGRY) | United States | $3.113B | 28.48 |
| GoodRx Holdings (GDRX) | United States | $2.900B | 110.43 |
| Agilon Health (AGL) | United States | $2.681B | 0.00 |
| Progyny (PGNY) | United States | $2.462B | 42.39 |
| NovoCure (NVCR) | Jersey | $2.052B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.013B | 7.98 |
| Premier (PINC) | United States | $1.950B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.819B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.647B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.141B | 0.00 | |
| CareDx (CDNA) | United States | $0.732B | 0.00 |
| Embecta (EMBC) | United States | $0.721B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.646B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| Enhabit (EHAB) | United States | $0.428B | 42.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.427B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| ModivCare (MODV) | United States | $0.368B | 6.88 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.289B | 0.00 |
| MultiPlan (MPLN) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.221B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Biodesix (BDSX) | United States | $0.196B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 5.72 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |